viczki

June Supplement 2019

Long-term limb surveillance after any revascularization is
strongly recommended.
Fifth, the guidelines address the current lack of
evidence supporting nonrevascularization therapies,
including cell-based and gene therapies, spinal cord
stimulation, pneumatic compression, prostanoids, and
hyperbaric oxygen treatment.
Finally, since most patients with CLTI have tissue loss,
either from an ischemic ulcer or gangrene, many
